TC
BSX icon

Tavio Capital’s Boston Scientific BSX Stock Holding History

Tavio Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-164,433
Closed -$7.44M – 8
2019
Q4 		$7.44M Hold
164,433
– – 2.74% 11
2019
Q3 		$6.69M Buy
+164,433
New +$6.97M 3.54% 8
2018
Q4 		– Sell
-24,671
Closed -$950K – 16
2018
Q3 		$950K Sell
24,671
-410,659
-94% -$14.3M 0.37% 18
2018
Q2 		$14.2M Sell
435,330
-280,164
-39% -$8.45M 4.82% 9
2018
Q1 		$19.5M Sell
715,494
-78,371
-10% -$2.13M 9.22% 4
2017
Q4 		$19.7M Sell
793,865
-900,501
-53% -$24.8M 10.74% 6
2017
Q3 		$49.4M Buy
1,694,366
+180,000
+12% +$4.97M 20.11% 2
2017
Q2 		$42M Buy
1,514,366
+117,925
+8% +$3.13M 20.89% 2
2017
Q1 		$34.7M Buy
+1,396,441
New +$34M 17.77% 3

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Tavio Capital's BSX Position: Q1 2020 in Review

Tavio Capital sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 164,433 shares — an estimated $7.44M sold.

Tavio Capital first reported a position in BSX in Q1 2017 and held it in 9 quarters. The position peaked at $49.4M in Q3 2017. 800 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

  • Tavio Capital reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
  • Tavio Capital sold 164,433 Boston Scientific shares in Q1 2020, an estimated $7.44M.
  • Tavio Capital first reported a position in Boston Scientific in Q1 2017 and held it in 9 quarters.
  • Tavio Capital's Boston Scientific position peaked at $49.4M in Q3 2017.
  • 800 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Tavio Capital's 13F filing for Q1 2020, filed 14 May 2020.